- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-7083
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities ; volume:9 ; number:1 ; day:4 ; month:4 ; year:2017 ; pages:1-15 ; date:12.2017
Clinical epigenetics ; 9, Heft 1 (4.4.2017), 1-15, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Micevic, Goran
- Contributor
-
Theodosakis, Nicholas
Bosenberg, Marcus
SpringerLink (Online service)
- DOI
-
10.1186/s13148-017-0332-8
- URN
-
urn:nbn:de:1111-201704226845
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Micevic, Goran
- Theodosakis, Nicholas
- Bosenberg, Marcus
- SpringerLink (Online service)
Other Objects (12)
Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma
Aberrant DNA methylation patterns in diabetic nephropathy
Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients
Aberrant DNA methylation of Tgfb1 in diabetic kidney mesangial cells
Aberrant DNA Methylation in Bladder Cancer among Saudi Arabia Population
Pan-cancer predictions of transcription factors mediating aberrant DNA methylation
Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer
Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency
Aberrant DNA methylation in t(8;21) acute myeloid leukemia
Tackling malignant melanoma epigenetically: histone lysine methylation
Opportunities for pharmacoproteomics in biomarker discovery
Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma
Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma
Aberrant DNA methylation patterns in diabetic nephropathy
Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients
Aberrant DNA methylation of Tgfb1 in diabetic kidney mesangial cells
Aberrant DNA Methylation in Bladder Cancer among Saudi Arabia Population
Pan-cancer predictions of transcription factors mediating aberrant DNA methylation
Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer
Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency
Aberrant DNA methylation in t(8;21) acute myeloid leukemia
Tackling malignant melanoma epigenetically: histone lysine methylation
Opportunities for pharmacoproteomics in biomarker discovery
Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma
Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma
Aberrant DNA methylation patterns in diabetic nephropathy
Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients
Aberrant DNA methylation of Tgfb1 in diabetic kidney mesangial cells
Aberrant DNA Methylation in Bladder Cancer among Saudi Arabia Population
Pan-cancer predictions of transcription factors mediating aberrant DNA methylation
Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer
Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency
Aberrant DNA methylation in t(8;21) acute myeloid leukemia
Tackling malignant melanoma epigenetically: histone lysine methylation
Opportunities for pharmacoproteomics in biomarker discovery